PSYCHOSIS TRIGGERED BY ZOLPIDEM: CLINICAL OBSERVATIONS FROM TWO ADULT CASES.

Main Article Content

Dr. Abhishek Kumar
Dr Brinda Shree
Dr. Pankaj Verma

Keywords

.

Abstract

Zolpidem, a non-benzodiazepine hypnotic commonly prescribed for insomnia, is generally considered safe for short-term use. However, adverse neuropsychiatric reactions, including psychosis, though rare, have been increasingly reported.

Abstract 0 | PDF Downloads 0

References

1. Sanger DJ, Zivkovic B. The pharmacology and mechanism of action of zolpidem. CNS Drug Rev. 1998;4(4):323–40.
2. Holm KJ, Goa KL. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59(4):865–89.
3. Tsai MJ, Huang TL. Zolpidem-induced psychosis in a patient with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(3):739–40.
4. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198–209.
5. Gunja N. The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013;9(2):155–62.
6. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198–209.
7. Hoque R, Chesson AL Jr. Z-drug dependency and withdrawal: Zolpidem and Zaleplon dependence. J Clin Sleep Med. 2009;5(6):498–9.
8. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction. 2003;98(10):1371–8.